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Abstract
Background: Despite being a highly prevalent chronic condition managed predominantly in primary care and unlike other chronic con-
ditions, osteoarthritis (OA) care is delivered on an ad hoc basis rather than through routine structured review. Evidence suggests current 
levels of OA care are suboptimal, but little is known about what general practitioners’ (GPs) consider important in OA care, and, thus, 
the scope to improve inconsistency or poor practice is, at present, limited.
Objectives: We investigated GPs’ views on and practice of monitoring OA.
Methods: This was a cross-sectional postal survey of 2500 practicing UK GPs randomly selected from the Binley’s database.  Respondents 
were asked if monitoring OA patients was important and how monitoring should be undertaken.
Results: Responses were received from 768 GPs of whom 70.8% were male and 89.5% were principals within their practices. Despite 
55.4% (n = 405) indicating monitoring patients with OA was important and 78.3% (n = 596) considering GPs the appropriate profes-
sionals to monitor OA, only 15.2% (n = 114) did so routinely, and 45% (n = 337) did not monitor any OA patients at all. In total, 61.4% 
(n = 463) reported that patients should self-monitor. Respondents favored monitoring physical function, pain, and analgesia use over 
monitoring measures of BMI, self management plans, and exercise advice.
Conclusions: The majority of respondents felt that monitoring OA was important, but this was not reflected in their reported current 
practice. Much of what they favored for monitoring was in line with published guidance, suggesting provision of suboptimal care 
does not result from lack of knowledge and interventions to improve OA care must address barriers to GPs engaging in optimal care 
provision.
Keywords: osteoarthritis, general practice, disease monitoring, chronic disease management
Clarson et al
86 Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders 2013:6
Introduction
Osteoarthritis (OA) is estimated to affect 9.6% of 
men and 18.0% of women over the age of 60 years 
worldwide and is one of the 10 most disabling dis-
eases in developing countries.1 One third of people 
aged 45 years and over in the UK have sought treat-
ment for OA,2 although this may only be the tip of 
the iceberg given that current evidence suggests 
many people who experience joint pain in the United 
Kingdom choose not to consult their GP.3 OA is a 
chronic condition, managed predominantly in pri-
mary care. It is associated with significant morbidity4 
and excess mortality,5 and there is no “magic bullet,” 
with management options limited largely to control 
of symptoms.
However, unlike other chronic conditions, in the 
United Kingdom, OA does not benefit from a struc-
tured approach to continuing care; patients consult in 
times of increased symptom burden, but are not neces-
sarily asked to return for review as a matter of course. 
This seems at odds with both the chronic nature of the 
condition and the symptom-based approach to man-
agement available to practitioners. Comparison could 
be drawn with chronic obstructive pulmonary disease 
(COPD), also chronic in nature with management 
options limited to symptom control, but in the United 
Kingdom, patients are annually routinely invited to 
attend their physician’s practice for a structured face-
to-face review where, among other things, breath-
lessness is scored and spirometry testing is repeated, 
offering an opportunity to monitor the progress of the 
condition and alter management to improve patients 
symptoms.
There is evidence that care provided to OA patients 
is not always optimal,6,7 and Steele et al report that of 
13 chronic conditions adherence with set quality indi-
cators was at its lowest in care for OA, reinforcing 
this lack of structured approach to OA management.8 
Given that the morbidity associated with OA remains 
a significant cost to both individuals and the health 
economy as a whole, by implication there is room for 
improvement in the way we care for patients with the 
disease.
There is evidence that a reduction in OA pain can 
result in improved function and general health status9,10 
and that simply by improving a patient’s experience 
of pain, without any biomechanical alteration, func-
tion can be improved.10 There is some  suggestion that 
there is a cost saving to be made from routine moni-
toring of certain factors in OA patients. Improving 
care for depression in those with OA has been shown 
not only to reduce depression, but also lessen pain 
intensity and interference with activities of daily liv-
ing and improve general health and quality of life.11
If monitoring, described as “repeated testing aimed 
at guiding and adjusting the management of a chronic 
or recurrent condition,”12 could offer an opportu-
nity to identify and address poor symptom control 
and functional impairment and screen for comorbid 
conditions such as depression, then by implication, 
it may also reduce the burden on individuals and the 
associated cost to the health service. Given that many 
patients suffering joint pain choose not to consult 
their GP, routine structured monitoring may offer the 
opportunity to “hang on” to those that do.
To date, there has been little research into the 
benefits of chronic disease monitoring as a whole, 
and yet, despite this, the model is in routine use for 
many chronic conditions. It is not understood why 
the chronic disease model has not been applied to OA 
and similarly why current levels of OA care are sub-
optimal, with little known about what general prac-
titioners (GPs) consider important in OA care. Thus, 
scope to improve inconsistency or poor practice is, 
at present, limited, and, with this in mind, we inves-
tigated GPs’ views on and their current practice of 
monitoring patients with OA.
Methods
ethical approval
The study was approved by the North Staffordshire 
Local Research Ethics Committee (09/H1204/65).
Participants
A random sample of 2500 GPs currently working in 
the United Kingdom was generated and obtained from 
the Binley’s database. Binley’s is a for-profit organi-
zation providing health professionals’ contact details, 
which are selected at random from a Microsoft Access 
database by assigning each record a unique random 
numerical identifier between 0 and 1 in addition to 
any existing database identifiers, ordering by the new 
random identifier, and then selecting the required 
number of records at random. The sample was sent 
an 8-page self-completion postal questionnaire, a 
reminder postcard was mailed after 2 weeks, and a 
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further copy of the questionnaire was sent 2 weeks 
after that.
Questionnaire design
Very little has previously been written about GPs’ 
views on the monitoring of osteoarthritis, so there were 
no existing validated questionnaires or tools located. 
The questionnaire was piloted at 2 general practices 
and at a local vocational training scheme afternoon 
teaching session in 2008. The purpose of the pilot 
was to ensure that the questionnaire was clear and 
easy to read, that the questions were not ambiguous, 
and that it could be completed in less than 10 minutes 
since target participants were busy GPs. On average, 
it took the pilot participants 15 minutes to complete 
the questionnaire fully, but this was deemed accept-
able by both the authors and all who took part.
Questionnaire content
Respondents were asked for demographic details, 
including gender, job title, and whether they had 
special interest in musculoskeletal medicine or addi-
tional postgraduate qualifications. They were then 
asked a series of questions about monitoring OA. 
The term “monitoring” was not further defined as 
no definition within this context exists in the current 
 literature. Respondents were asked whether they con-
sider monitoring to be important for patients with OA 
with options of “yes” or “no.” They were then asked 
whether they routinely monitor OA patients, with 
options of “yes,” “no,” or “some.” If they answered 
“some,” they were asked to including an estimate 
of the proportion of patients with the disease they 
 monitor. A list of potential components to monitor 
and healthcare professionals who should be respon-
sible for monitoring were included, and respondents 
asked to select as many as they felt were appropriate 
from the list. Respondents were also asked to indi-
cate the frequency of monitoring they felt should 
be undertaken, selecting from options which ranged 
from monthly to annually. A pilot study was under-
taken using a group of North Staffordshire general 
practitioners. Copies of the questionnaire are avail-
able from the lead author on request.
Statistical analysis
The results were analyzed using PASW Statis-
tics 18, release 18.0.0 (SPSS, Inc., Chicago, IL). 
Descriptive statistics were used followed by a chi-
square test to determine significant associations. 
Respondents with missing data were included, and the 
complete data for individual questions was analyzed.
Results
Of the 2500 questionnaires sent, 768 were returned 
completed (30.7%). Overall, 70.4% (n = 541) of 
respondents were male, and 89.1% (n = 684) were 
principals within their practices. Characteristics of 
respondents are summarized in Table 1.
The majority of respondents (55.4%; n = 405) 
felt that monitoring patients with OA was important. 
Having a special interest in musculoskeletal disease 
(χ2 = 7.66, P = 0.006), an awareness of the National 
Institute for Clinical Excellence (NICE) OA guide-
lines (χ2 = 10.02, P = 0.002) and possessing a mas-
ters (χ2 = 6.169, P = 0.013) or doctoral (χ2 = 7.60, 
P = 0.006) level higher medical qualification were 
significantly associated with considering monitoring 
OA important.
Overall, only 15.2% (n = 114) of respondents mon-
itored OA patients routinely. Considering monitoring 
important (χ2 = 209.34, P = ,0.001), having a spe-
cial interest in musculoskeletal disease (χ2 = 15.16, 
P = ,0.001), having attained a Masters degree 
(χ2 = 6.15, P = 0.046), having read the NICE guide-
lines (χ2 = 20.15, P , 0.001) and working full time 
Table 1. Demographic characteristics of respondents.
characteristics Respondents  
to the survey  
(n)
Respondents 
to the survey 
(%)a
Gender
Male 541 70.4
Female 223 29.0
Missing 4 0.5
Job title
Partner 684 89.1
Salaried 29 3.8
Missing 55 7.2
Special interest  
in MSMb
176 22.9
size of practice (number of registered patients)
Small (,4000) 183 23.8
Medium (4000–7999) 294 38.3
Large (.8000) 291 37.9
Missing 0 0
notes: aTotal may not equal 100 due to rounding; bMSM denotes 
musculoskeletal medicine.
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(χ2 = 6.18, P = 0.046) were significantly associated 
with monitoring some or all OA patients routinely. 
Nearly half (45%, n = 337) did not routinely moni-
tor any OA patients, citing increased workload and 
lack of resources, replication of work undertaken at 
existing annual medication reviews, and reluctance to 
medicalize such a common condition as the main rea-
sons for this. Over one-third (39.8%, n = 298) reported 
monitoring some OA patients, with participants indi-
cating that severity of disease, regular prescription 
of analgesia, and comorbidities were the factors by 
which those requiring monitoring were chosen.
Of those who considered monitoring important, 
only 27.7% (n = 112) monitored OA patients routinely, 
with 49.1% (n = 199) monitoring some OA patients 
selected for similar reasons to those reported above. 
Nearly a quarter (22.5%, n = 91) reported not monitor-
ing any OA patients despite considering it important, 
with the most common reasons given by participants 
for this inconsistency in practice being workload and 
time constraints and the desire to encourage patient 
self-monitoring.
The most popular interval for monitoring was 
annually, favored by 45.3% (n = 275) of respondents; 
33.6% (n = 204) favored 6 to 12 month intervals, 
with only 21.1% (n = 128) suggesting more frequent 
intervals.
Respondents indicated that pain and function 
should be monitored. Preferred indicators for moni-
toring pain included analgesia use favored by 84.1% 
(n = 646) and pain intensity by 79.9% (n = 614). Most 
respondents favored simply asking the patient about 
how severe their pain was, but both visual analogue 
scales and 10-point numerical rating scales were sug-
gested by participants. Indicators of function respon-
dents felt should be monitored included level of 
disability, supported by 83.3% (n = 640), and inter-
ference of symptoms with activities of daily living, 
supported by 81.8% (n = 628). Less than half (43.9%, 
n = 281) suggested how this might be achieved, 10% 
(n = 30) of whom referred to a standardized assess-
ment tool, but only 1.4% (n = 4) were able to name a 
specific tool that might be used for this purpose. X-ray 
changes were least popular for monitoring, favored 
by only 22.1% of respondents. The results are shown 
in Table 2 from most popular to least popular.
The majority of respondents (78.3%, n = 596) 
thought that the GP should be the key professional 
Table 2. Potential components to monitor in OA patients.
Factor to be monitored number  
“Yes”
% “Yes”
Analgesia use 646 84.1
Level of disability 640 83.3
Interference with activities  
of daily living
628 81.8
Pain intensity 614 79.9
NSAID use 600 78.1
Analgesic side effects 597 77.7
BMI 570 74.2
Quality of life 541 70.4
Pain duration 529 68.9
Adherence with exercise advice 504 65.6
Mood 484 63.0
Social aspects of care 462 60.2
Self management plan 450 58.6
Widespread pain 429 55.9
X-ray changes 170 22.1
involved in monitoring patients with OA, although 
both the practice nurse and physiotherapist were 
also popular choices, favored by 42.7% (n = 325) 
and 44.5% (n = 339) respectively. Two-thirds of 
respondents (61.4%, n = 463) highlighted the role of 
patients in self-monitoring their condition, and over 
half (53.1%, n = 404) selected 2 options indicating 
shared responsibility between the GP and the patient. 
 Secondary care was a less popular setting for the 
routine monitoring of OA, although still favored by 
nearly one-third (31.5%, n = 204) of respondents.
Discussion
The majority of GPs participating in this study felt that 
monitoring patients with OA was important, in line 
with current national and international guidance,13–16 
and that GPs were the most appropriate group to under-
take this task. However, this was not reflected in their 
reported current practice: only 15% indicated that they 
monitored OA routinely, and 45% indicated that they 
did not monitor any of their OA patients.
How GPs define monitoring is clearly integral to 
the way that they responded to the questionnaire, 
although there is little in the literature to describe this. 
In the United Kingdom, chronic disease monitoring 
is dominated by the Quality and Outcomes Frame-
work (QOF), a voluntary scheme by which high qual-
ity primary care is incentivized.17 Each condition 
included within the QOF has a set of key indicators 
for the provision of care, and points are awarded for 
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the attainment of these, with points then translating 
into financial reward. An annual disease “review” is 
a common component of many of the chronic dis-
ease domains of QOF, such as diabetes and asthma, 
where information is collected from patients about 
their current condition, any changes or concerns, 
and monitoring tests (such as spirometry in COPD) 
can be performed. It would seem likely that this cur-
rent model informed the participants’ perceptions of 
“monitoring,” since the preference for annual moni-
toring indicated by respondents reflects the frequency 
required for QOF reviews and current guidance on the 
management of OA does not recommend a monitor-
ing interval with which to compare.13–16 For this rea-
son, it may be possible that some of the respondents’ 
views reflect their current experience of and views on 
QOF, rather than the condition of OA itself.
In order to maximize available resources, much 
of the chronic disease monitoring required for condi-
tions within QOF has been delegated to practice nurses, 
whereas the majority of respondents felt that GPs 
should have responsibility for monitoring OA. Similar 
but smaller proportions of GPs thought that physiother-
apists and practice nurses should monitor OA. While 
practice nurses are frequently involved in chronic dis-
ease reviews in primary care, disease monitoring is not 
a role that many physiotherapists are likely to be famil-
iar with, and most practices do not have a physiothera-
pist attached to undertake routine work. This increased 
demand on physiotherapy services, simply for monitor-
ing, is unlikely to be met with the current workforce.
One-third of GPs indicated that monitoring of OA 
should take place in secondary care. There is evidence 
to suggest that GPs’ attitudes and referral behaviors 
are strongly influenced by their general orientation 
to the importance of preventive care, as well as how 
they measured a successful outcome, with belief (or 
lack of it) in the potential effectiveness of a service 
considered a key element in referring behaviors.18 
In the management of OA, there are few tools in the 
secondary care armory that are not available in pri-
mary care, and the majority of respondents preferring 
primary over secondary care for monitoring OA may 
reflect an uncertainty that secondary care has more 
to offer. Alternatively, given that the majority of OA 
patients are managed entirely in primary care, these 
respondents may primarily have been considering 
those with the most severe disease if routine care for 
OA was considered appropriate as reason for sec-
ondary care referral. However, if one-third of GPs 
genuinely feel that secondary care is the appropri-
ate setting in which to monitor all OA patients, then 
potential implementation would require a significant 
increase in resources.
Two-thirds of respondents highlighted the role of 
patients in self-monitoring their condition, and over 
half selected 2 options indicating shared responsibility 
between the GP and the patient. This reflects published 
recommendations from Arthritis and Musculoskeletal 
Alliance (ARMA) and Osteoarthritis Research Society 
International (OARSI), although current evidence does 
not support the effectiveness (or cost-effectiveness) 
of many self- management programs, including those 
delivered solely by specially trained GPs.19 Improve-
ments have been demonstrated using educational inter-
ventions delivered by GPs along with reinforcement 
from practice nurses,20 supporting a multidisciplinary 
primary care model in the monitoring of OA patients.
This multidisciplinary model may be key to mov-
ing towards a proactive approach to managing OA, 
as it has been in other conditions, such as COPD. In 
order to facilitate the monitoring of patients with OA, 
a similar model of regular review in primary care 
would be required. Given the potential variation in 
severity of OA, a one-size-fits-all approach may not 
be enough to optimize care for all OA patients. It is 
likely that for many, an annual review with a prac-
tice nurse to discuss symptoms, self-management 
techniques, and reiterate the importance of weight 
management and exercise, in line with current guid-
ance, would suffice.13–16 However, clearly those with 
more severe disease or difficulty in self-management 
may require more frequent review or intensive input 
and thus require additional appointments with a GP 
or even secondary care. With increasing demands on 
GPs from patients living longer with chronic condi-
tions and multimorbidity, and from the administrative 
burdens of quality indicators such as those included 
in QOF, there is limited capacity in the current system 
for the additional time and resources required to pro-
vide an increased level of care to patients with OA. 
Extra financial support to undertake this additional 
workload in primary care could come in the form of 
incentives through the addition of OA to QOF, or per-
haps through efficiency savings made by streamlining 
individual disease reviews for patients with multiple 
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long-term conditions, including OA, into one multi-
morbidity review, appropriately utilizing the wider 
primary care team and reducing the additional burden 
on GPs themselves.
Candidate items selected by GPs for monitoring were 
in line with current evidence-based guidelines, suggesting 
that suboptimal care does not result from lack of knowl-
edge, but may further reflect concerns around increased 
time and resource required to proactively manage aspects 
of a condition such as OA. Pain, physical function, and 
analgesia use were preferred as potential monitoring tar-
gets, despite the absence of a standardized validated tool 
to measure pain and physical function brief enough to be 
acceptable in primary care. In contrast, other interven-
tions such as body mass index monitoring and adher-
ence to exercise advice, which may potentially be easier 
to measure but more time consuming to discuss, were 
less popular. This may suggest that respondents do not 
consider these factors as modifiable contributors to the 
course of OA, but there is evidence to suggest that lack 
of time, lack of confidence in providing advice and effec-
tiveness of interventions, lack of reimbursements, and 
lack of patient compliance and motivation are the major 
barriers to GPs discussing lifestyle interventions such as 
exercise and weight loss with patients.21 Tackling these 
barriers would be vital to any change in the delivery of 
care for patients with OA, since lifestyle modification 
is key to the management of this condition. While the 
results of our survey support these findings, with work-
load and lack of time the most frequently cited reasons 
for not monitoring OA patients routinely, despite con-
sidering monitoring important, the factors that govern 
GPs individual practice in the management of OA have 
not been explored in the literature. Our findings demon-
strate that focus should not be upon the importance of 
monitoring of patients with OA, since the majority are in 
agreement with this, but rather in increasing those who 
actually undertake monitoring routinely. More detailed 
qualitative work is required to understand why this dis-
crepancy exists and to identify factors that influence GPs’ 
willingness to adopt monitoring in patients with OA and 
may provide barriers to change.
One limitation of this survey is the response rate. 
Low response rates are not uncommon in surveys of 
physicians,22 and while low response does not auto-
matically result in biased findings, caution is needed 
when interpreting our findings.
Comparison of respondents with the UK population 
is difficult due to a paucity of available information. 
The majority of respondents were male (70%), and this 
is true of the GP population in England (52%).23 The 
majority of respondents identified themselves as GP 
principals (89%), and this is also true of the GP popula-
tion in England (68%).23 Female GPs and nonprincipal 
(eg, salaried, locum, and sessional) GPs appear to be 
underrepresented in our sample, and these 2 discrep-
ancies would seem to fit together since, in England, 
female GPs only constitute a minority (39%) of GP 
principals.23 While no data about gender were held for 
nonrespondents, the majority of nonrespondents were 
also GP principals, and so response bias cannot neces-
sarily be inferred. Nonprincipal GPs are more likely to 
be a mobile population and thus difficult to contact in 
a postal survey of this nature.  However, it should also 
be considered that they typically have less continuity 
of care with patients and, as such, may have different 
opinions about monitoring chronic disease that are not 
represented in these findings.
At present there is no evidence to suggest whether 
monitoring patients with OA can improve outcome 
despite clinicians’ beliefs that monitoring is important 
for this group. Further work is needed to assess the 
effectiveness (and cost-effectiveness) of routine mon-
itoring compared with “usual” care and to develop an 
evidence-based core set of indicators that could be 
implemented into routine practice to enhance clinical 
care for this group.
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